PMID: 25730905Mar 3, 2015Paper

Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase

Oncotarget
Jelani C ZarifC K Miranti

Abstract

Castration-resistant prostate cancers still depend on nuclear androgen receptor (AR) function despite their lack of dependence on exogenous androgen. Second generation anti-androgen therapies are more efficient at blocking nuclear AR; however resistant tumors still develop. Recent studies indicate Src is highly active in these resistant tumors. By manipulating AR activity in several different prostate cancer cell lines through RNAi, drug treatment, and the use of a nuclear-deficient AR mutant, we demonstrate that androgen acting on cytoplasmic AR rapidly stimulates Src tyrosine kinase via a non-genomic mechanism. Cytoplasmic AR, acting through Src enhances laminin integrin-dependent invasion. Active Matriptase, which cleaves laminin, is elevated within minutes after androgen stimulation, and is subsequently shed into the medium. Matriptase activation and shedding induced by cytoplasmic AR is dependent on Src. Concomitantly, CDCP1/gp140, a Matriptase and Src substrate that controls integrin-based migration, is activated. However, only inhibition of Matriptase, but not CDCP1, suppresses the AR/Src-dependent increase in invasion. Matriptase, present in conditioned medium from AR-stimulated cells, is sufficient to enhance invasion ...Continue Reading

References

Jan 1, 1997·Annual Review of Physiology·M Wehling
Jan 1, 1997·Annual Review of Cell and Developmental Biology·S M Thomas, J S Brugge
Mar 20, 2002·Nature Reviews. Cancer·B J Feldman, D Feldman
Jun 20, 2002·Methods in Cell Biology·Cindy K Miranti
Jan 2, 2004·Nature Medicine·Charlie D ChenCharles L Sawyers
Jun 2, 2004·Nature Reviews. Cancer·Timothy J Yeatman
Jun 5, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Hong-Yo KangKo-En Huang
Aug 4, 2004·Steroids·Gabriella CastoriaFerdinando Auricchio
Sep 6, 2005·Cancer Research·Irina U AgoulnikNancy L Weigel
May 10, 2006·Proceedings of the National Academy of Sciences of the United States of America·Li XinOwen N Witte
Nov 30, 2006·Cellular and Molecular Life Sciences : CMLS·K Uhland
Jul 17, 2008·Nature Clinical Practice. Oncology·Bostjan Seruga, Ian F Tannock
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Susan WeeChristoph Lengauer
Jan 30, 2009·Cell Cycle·Dmitri WiederschainJohn D Benson
Jul 4, 2009·Cancer Cell·Xiang H-F ZhangJoan Massagué
Aug 13, 2009·Molecular Cancer Research : MCR·Elena I DeryuginaJames P Quigley
May 13, 2010·Cancer Research·Dimple ChakravartyRatna K Vadlamudi
Dec 8, 2010·Cancer Research·Houjian CaiOwen N Witte
May 12, 2011·PloS One·Danislav S SpassovMark M Moasser
Nov 10, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R J van SoestW M van Weerden
Feb 14, 2014·Cancer Metastasis Reviews·Andreas VarkarisPaul G Corn
Jun 3, 2014·European Urology·Eleni EfstathiouChristopher J Logothetis
Sep 17, 2014·Nature Reviews. Urology·Frank ClaessensSteven Joniau

❮ Previous
Next ❯

Citations

Oct 28, 2015·Oncotarget·Erika Di ZazzoAntimo Migliaccio
Feb 2, 2017·Frontiers in Endocrinology·Jacky K Leung, Marianne D Sadar
Nov 28, 2018·Nature Reviews. Urology·Emma E van der ToomKenneth C Valkenburg
Feb 23, 2019·The Journal of Biological Chemistry·Prachi BajpaiKeshav K Singh
Mar 8, 2018·Oncogene·Sara G PollanBeatrice S Knudsen
Mar 6, 2019·International Journal of Molecular Sciences·Francesca De AmicisVincenzo Pezzi
Oct 17, 2019·Frontiers in Chemistry·Alice ZamagniAnna Tesei
Oct 16, 2015·BMC Cancer·Yabing ZhengXiaotian Chang
Jun 9, 2015·Endocrine Reviews·Päivi PihlajamaaOlli A Jänne
May 6, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jieping HuTing Sun
Aug 16, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Vladimíra PavlíčkováTomáš Ruml
Sep 19, 2019·Cancer Metastasis Reviews·Carly E Martin, Karin List
Dec 30, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Gabriella CastoriaAntimo Migliaccio
Sep 30, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Johannes BrägelmannSven Perner
Nov 23, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Emma H AllottLorelei A Mucci
Nov 22, 2017·Steroids·Hannah Weber, Michael J Garabedian
Apr 20, 2021·Journal of the Endocrine Society·Olga AstapovaStephen R Hammes
Jul 30, 2021·The Journal of Antibiotics·Yohko YamazakiManabu Kawada
Jul 11, 2021·Cancer Discovery·Romain RiscalM Celeste Simon
Nov 19, 2021·Endocrine Reviews·Franck Mauvais-JarvisEllis R Levin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.